Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary S Wolfe

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Lippincott'S Case Management : Managing the Process of Patient Care|February 3, 2005
Hepatitis C: the latest epidemicGary S Wolfe
Lippincott'S Case Management : Managing the Process of Patient Care|June 3, 2005
Hepatitis C-diagnosis and treatmentGary S Wolfe
Lippincott'S Case Management : Managing the Process of Patient Care|August 2, 2005
Hepatitis C--who should be treated?Gary S Wolfe
Lippincott'S Case Management : Managing the Process of Patient Care|April 9, 2005
Hepatitis C: laboratory tests to be done before the diagnosis can be madeGary S Wolfe
Journal of Diabetes Science and Technology|January 10, 2012
Accuracy of dosage volume for halfway doses in the Victoza PenAllen B King, Gary S Wolfe
Journal of the American Academy of Nurse Practitioners|January 8, 2009
Evaluation of a diabetes specialist-guided primary care diabetes treatment programAllen B King, Gary S Wolfe
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 24, 2012
How much do I give? Dose estimation formulas for once-nightly insulin glargine and premeal insulin lispro in type 1 diabetes mellitusAllen B King, Dawn Clark, Gary S Wolfe
Diabetes Technology & Therapeutics|August 1, 2012
The number of basal rates required to achieve near-normal basal glucose control in pump-treated type 2 diabetesAllen B King, Dawn Clark, Gary S Wolfe
Journal of Diabetes Science and Technology|August 6, 2013
Titrating beyond glycemic goal: "post-glycemic target phenomenon"Allen B King, Dawn Clark, Gary S Wolfe
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 3, 2012
Contribution of the dawn phenomenon to the fasting and postbreakfast hyperglycemia in type 1 diabetes treated with once-nightly insulin glargineAllen B King, Dawn Clark, Gary S Wolfe
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Lippincott'S Case Management : Managing the Process of Patient Care|February 3, 2005
Hepatitis C: the latest epidemicGary S Wolfe
Lippincott'S Case Management : Managing the Process of Patient Care|June 3, 2005
Hepatitis C-diagnosis and treatmentGary S Wolfe
Lippincott'S Case Management : Managing the Process of Patient Care|August 2, 2005
Hepatitis C--who should be treated?Gary S Wolfe
Lippincott'S Case Management : Managing the Process of Patient Care|April 9, 2005
Hepatitis C: laboratory tests to be done before the diagnosis can be madeGary S Wolfe
Journal of Diabetes Science and Technology|January 10, 2012
Accuracy of dosage volume for halfway doses in the Victoza PenAllen B King, Gary S Wolfe
Journal of the American Academy of Nurse Practitioners|January 8, 2009
Evaluation of a diabetes specialist-guided primary care diabetes treatment programAllen B King, Gary S Wolfe
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 24, 2012
How much do I give? Dose estimation formulas for once-nightly insulin glargine and premeal insulin lispro in type 1 diabetes mellitusAllen B King, Dawn Clark, Gary S Wolfe
Diabetes Technology & Therapeutics|August 1, 2012
The number of basal rates required to achieve near-normal basal glucose control in pump-treated type 2 diabetesAllen B King, Dawn Clark, Gary S Wolfe
Journal of Diabetes Science and Technology|August 6, 2013
Titrating beyond glycemic goal: "post-glycemic target phenomenon"Allen B King, Dawn Clark, Gary S Wolfe
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 3, 2012
Contribution of the dawn phenomenon to the fasting and postbreakfast hyperglycemia in type 1 diabetes treated with once-nightly insulin glargineAllen B King, Dawn Clark, Gary S Wolfe
Pageof 2